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A B S T R A C T
The nuclear vitamin D receptor (VDR) is generally recognized as a ligand-dependent transcription factor
that mediates the actions of its natural ligand, 1a,25-dihydroxyvitamin D3 (1a,25(OH)2D3) on multiple
target genes involved in mineral homeostasis, bone development, as well as immune reactivity. As the
VDR is widely distributed in nearly all cells of the body, it implies that the vitamin D endocrine system
may regulate many cell types and functions. Experiments in VDR null mice established that the VDR has
intrinsically critical roles in skin and keratinocyte biology but not in immune responses. Oppositely,
absence of the VDR ligand is linked to susceptibility to autoimmunity, illustrating a potential role for the
unliganded VDR in the immune system. This discrepancy stimulated us to further investigate the impact
of the VDR on the phenotype and function of myeloid dendritic cells (DCs) generated ex vivo from bone
marrow precursors of VDR null (with a truncated VDR) and VDR DAF2 mice (with a mutated C-terminal
activation factor 2 domain thus rendering ligand-induced gene transcription impossible). Absent or
unliganded VDR did not affect bone marrow-derived myeloid DC generation. DCs obtained from VDR null
and VDR DAF2 bone marrow cells had comparable MHC-II, and costimulatory molecule CD86, CD80 and
CD40 expression than DCs from wild-type bone marrow cells. Additionally, an unliganded VDR did not
affect the cytokine production nor the antigen-speciﬁc T cell stimulatory capacity of bone marrow-
derived DCs. In conclusion, we showed that although clear effects of 1a,25-dihydroxyvitamin D3 are
described on DC generation, absence of VDR or presence of an unliganded VDR does not affect the proﬁle
and function of ex vivo generated bone marrow-derived DCs.
ã 2015 Elsevier Ltd. All rights reserved.
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The vitamin D receptor (VDR) is a member of a family of nuclear
transcription factors. The VDR regulates gene expression through
heterodimerization with the retinoid X receptor (RXR), both in the
absence or presence of its natural ligand, 1a,25-dihydroxyvitamin
D3 (1a,25(OH)2D3), and recruits co-repressors or co-activators to
vitamin D-responsive elements (VDREs) in the promoter region of
target genes. The VDR protein consists of 2 major functional units:
a DNA binding domain (DBD) with two zinc ﬁngers at the N-
terminus, enabling the receptor to associate with the DNA, and a C-
terminal ligand binding domain (LBD). Ligand binding will induce a
crucial conformational change in the helix 12 motif, corresponding
to the transcriptional activation domain designated AF-2, releasing
associated co-repressors while a platform is created to recruit the
co-regulatory complex and gene transcription is initiated [1–3].
The VDR has a widespread expression throughout the body.
Therefore, interaction of the VDR with 1a,25(OH)2D3 results in the
regulation of multiple target genes responsible for effects in
mineral homeostasis, bone development, as well as immune
reactivity [4]. In case of absence of 1a,25(OH)2D3, the VDR–RXR
complex recruits co-repressors to the VDREs resulting in tran-
scriptional repression mediated by histone deacetylation. Recently,
it has been recognized that the VDR protein independent of ligand
may also have functional importance.
As a result of VDR expression in the immune system, 1a,25
(OH)2D3 presents direct immunomodulatory effects on different
immune cells, of which dendritic cells (DCs) are the major targets.
DCs act as professional antigen-presenting cells providing a link
between innate and adaptive immune responses. Immature DCs,
resident in peripheral tissues, are specialized in capturing antigens
and are able to respond to microbial and inﬂammatory stimuli.
Upon encounter with maturation stimuli, DCs will alter the
expression of several molecules, such as the antigen-presenting
molecule major histocompatibility complex (MHC) II, co-stimula-
tory molecules (e.g. CD40, CD80, and CD86) and chemokine
receptors (e.g. CCR7), in order to become potent T cell stimulators.
In addition, the mature DC can direct the T cell response by the
production of T helper (Th)-polarizing cytokines (e.g. IL-12, IL-23,
IL-10) and pro-inﬂammatory cytokines [5]. In mice and man,
mainly, DCs of two origins, myeloid and lymphoid, have been
identiﬁed but their location in various organs, as well as
phenotypes and functions are incompletely described. Both
lineages can be generated ex vivo from the bone marrow under
stimulation of different growth factors (e.g. granulocyte macro-
phage colony stimulating factor (GM-CSF)/interleukin (IL)-4
[myeloid or conventional DCs] and Flt-3 ligand [plasmacytoid
DCs]). Upon binding of 1a,25(OH)2D3 to the VDR, both the
differentiation and maturation of particularly myeloid DCs will be
inhibited, leading to reduced cell surface expression of CD40, CD80,
and CD86 costimulatory molecules, reduced T cell stimulatory
function, and decreased survival [6,7].
Interestingly, epidemiological data show a strong correlation
between vitamin D3 deﬁciency and adverse immune effects,
including inﬂammation and autoimmunity [8–10]. In addition,
vitamin D3 deﬁciency during early life increases the incidence andPlease cite this article in press as: A.-S. Vanherwegen, et al., The phenotyp
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while absence of ligand accelerates disease, lack of the VDR does
not show aggravated symptoms [13,14]. Moreover, in the skin VDR
ablation causes total body alopecia and dermal cysts while
vitamin D3-deﬁciency does not result in a hair cycle/skin
phenotype [15]. This discrepancy between absence of either
ligand or receptor indicates important actions for the unliganded
VDR in several tissues, but also in the regulation of immune
responses.
To study the effects of an unliganded VDR, the Tokyo VDR null
and the VDR DAF-2 mouse models were used. The VDR null strain
was generated by a targeted deletion of the second exon of the VDR
gene encoding the ﬁrst zinc ﬁnger domain in the DBD of the
nuclear receptor [16] resulting in a truncated VDR [17], which is
unable to bind to VDREs, but contains intact LBD and AF2 motifs.
The VDR DAF-2 mouse model has a deletion of exon 8 and 9
encoding the AF-2 domain, which destroys VDR function. Although
DNA binding is still possible, DNA remains associated with co-
repressors as the transcriptional initiation complex cannot be
recruited. In case of negative VDREs, the VDR will be associated
with the transcription machinery. This is similar to the condition of
absent 1a,25(OH)2D3 resulting in an unliganded VDR which is
likewise associated with co-repressors.
In the current study, we aimed thus to establish whether the
presence of an unliganded VDR could interfere with the genera-
tion, phenotype and function of ex vivo generated bone marrow-
derived myeloid DCs (BMDCs). Taken together, our data indicate
that BMDCs derived from VDR DAF-2 mice presenting an
unliganded VDR did not differ in surface marker expression,
cytokine production nor in T cell proliferative capacity compared to
BMDCs derived from wild-type (WT) or VDR null mice.
2. Materials and methods
2.1. Animal models
The VDR null [16] and VDR DAF-2 mouse strain were kind gifts
of Dr. S. Kato, University of Tokyo, Tokyo, Japan). WT C57BL/6, VDR
null and VDR DAF-2 breeding pairs and weaned pups were
housed in SPF conditions and kept on a calcium/lactose-enriched
diet (2% calcium, 1.25% phosphate, 20% lactose and 1400 IU/kg
Vitamin D3; Ssniff Spezialdiäten, Soest, Germany). OT-II transgenic
(Tg) mice, which carry the MHC class II-restricted Tg T cell receptor
for OVA323–339, were kindly provided by Prof. M. Moser (ULB,
Brussels, Belgium) and further bred in our conventional animal
facility on normal chow. All experimental protocols were reviewed
by the Ethics Committee of the KU Leuven (Project number P221/
2013).
2.2. Generation of myeloid DCs
BMDCs were generated from 3 to 4 week-old mice according to
a previously established protocol [6,18]. Brieﬂy, bone marrow
precursors were cultured in RPMI 1640 medium (Life Technologies,
Rockville, MD, USA) supplemented with Glutamax-I, 25 mM
HEPES, 10% heat-inactivated fetal calf serum (FCS) (Thermoe and function of murine bone marrow-derived dendritic cells is not
in D3, J. Steroid Biochem. Mol. Biol. (2015), http://dx.doi.org/10.1016/
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(UCB, Brussels, Belgium) and 100 U/ml Penicillin/Streptomycin in
the presence of 20 ng/ml murine recombinant IL-4 and 20 ng/ml
murine recombinant GM-CSF (Peprotech, Rocky Hill, NJ, USA) for 8
days. At day 8 of the culture, CD11c+ cells were magnetically
isolated (MACS, Miltenyi Biotec, Bergish Gladblach, Germany) and
subsequently maturated for an additional 24 h in the presence of
1 mg/ml LPS (Sigma, St. Louis, MO, USA) and 20 ng/ml murine
recombinant interferon (IFN)-g (Peprotech). Mature DCs were
harvested at day 9 of the in vitro culture and subjected to
phenotypical analyses. To assess their T cell proliferative capacity,
DCs were pulsed with 0.1 mg/ml OVA323–339 peptide (Innovagen,
Lund, Sweden) for 2 h at 37 C prior to co-culture with CD4+CD25
OVA323–339-reactive T cells.
2.3. Surface marker expression
BMDCs were analysed for their surface marker expression using
ﬂow cytometry. DCs were stained with antibodies against CD11c,
MHC-II (I-A/I-E), CD80, CD86, CD40, PD-L1 or F4/80 (all from
eBioscience). Matching isotype IgG antibodies were used as a
negative controls. After extensive washing and ﬁxation, the stained
cells were analysed using a GalliosTM Flow Cytometer (Beckmann
Coulter, Analis, Suarlée, Belgium).
2.4. Gene expression analysis
mRNA was isolated using the RNeasy Micro kit (Qiagen, Venlo,
The Netherlands). After cDNA synthesis, gene expression levels
were determined by RT-qPCR using StepOnePlus Real-Time PCRc11
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Fig. 1. Surface marker expression of BMDCs. DCs were generated in vitro from the bone m
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probe sequences used for the detection of hmbs, hprt, il-1b, il-6, il-
10, il-12p40, inos, ip-10, rpl27, tnf-a (Eurogentec, Seraing, Belgium)
are listed in Supplemental Table 1. Gene expression was quantiﬁed
by the DDCt method and normalized against the geometrical mean
of hmbs, hprt and rpl27 expression.
2.5. Cytokine secretion
A V-plex Proinﬂammatory Panel 1 (mouse) kit MSD MULTI-
SPOT Assay System (Meso Scale Discovery, Rockville, MD, USA) was
used, following the manufacturer’s instructions, for the quantita-
tive detection of the secreted levels of IL-10, IL-12p70, IL-1b, IL-6
and TNF-a in DC culture supernatants or IL-10 and IFN-g in the DC:
T cell co-culture supernatants.
2.6. In vitro T cell proliferation assay
T cells were puriﬁed from the spleen and lymph nodes of 8-10
week-old OT-II Tg mice using magnetic separation with Dynabeads
(Invitrogen, Merelbeke, Belgium). Brieﬂy, CD4+CD25 T cells were
isolated by negative selection using antibodies against CD16/CD32,
CD11b, CD11c, B220, MHC-II, CD8a and CD25 (all from eBio-
science). Isolated T cells (105/ml) were co-cultured with OVA323–
339-pulsed mature DCs at a 1:10 DC:T cell ratio in complete
medium (RPMI 1640 supplemented with Glutamax-I, 25 mM
HEPES, 10% FCS, 50 mM 2-ME, 100 U/ml Penicillin/Streptomycin,
1 mM glutamine and 1 mM Na-Pyruvate) for 3 days. T cell
proliferation was determined by 3H-thymidin (1 mCi/well) incor-
poration during the last 18 h of co-culture.86
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Statistical signiﬁcance was determined using Kruskal–Wallis
test with Dunn’s multiple comparisons or a one sample t test.
Results were expressed as mean  standard error of the mean
(SEM). All statistical analyses were performed using GraphPad
Prism 6 software (GraphPad Software, La Jolla, CA, USA).
3. Results
3.1. An unliganded VDR has no inﬂuence on murine BMDC generation
and phenotype
To determine whether the unliganded VDR plays a role in BMDC
generation or phenotype, DCs generated ex vivo from bone marrow
precursors of WT, VDR null and VDR DAF-2 mice were analysed for
their surface marker expression by ﬂow cytometry. We ﬁrst
established that LPS and IFN-g are potent maturation/activation
stimuli in BMDCs from the three mouse strains (Fig.1). Comparison
of either unstimulated or stimulated BMDCs derived from WT, VDR
null and VDR DAF-2 mice clearly showed no differences in the
surface expression levels of the antigen-presenting molecule
MHC-II, the co-stimulatory molecules CD86, CD80 and CD40, and
the inhibitory molecule programmed death ligand 1 (PD-L1)
(Fig. 1).
When analysing the BMDC cytokine and chemokine gene
expression proﬁle, a few changes could be observed between
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were signiﬁcantly up-regulated in VDR null BMDCs (as compared
to WT BMDCs, *p < 0.05).
To validate the observed changes in cytokine and chemokine
gene expression, the secretion levels of several proteins into the
supernatant of stimulated DC cultures was determined. Interest-
ingly, protein levels of IL-12p70, IL-10, IL-6, TNF-a and IL-1b
(Fig. 3) did not show signiﬁcant differences between mature
BMDCs generated from WT, VDR null or VDR DAF-2 mice.
3.2. An unliganded VDR did not inﬂuence the in vitro T cell stimulatory
capacity of murine BMDCs
As primarily mature BMDCs are potent T cell stimulators, we
next investigated the functional impact of an unliganded VDR on
the T cell stimulatory capacity of BMDCs. For this purpose, BMDCs
were loaded with 0.1 mg/ml OVA323–339 peptide and co-cultured
for 72 h with CD4+CD25 T cells derived from OT-II Tg mice. As
shown in Fig. 4, VDR DAF-2 DCs did not present a higher T cell
stimulatory capacity as compared to WT or VDR null DCs (Fig. 4A).
In agreement with this, no signiﬁcant changes in the secreted
levels of IFN-g (Fig. 4B) and IL-10 (Fig. 4C) into the co-culture
supernatant were observed.
4. Discussion
The widespread expression of the VDR in immune cells [4] as
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an important role for the VDR and its ligand in the regulation of
immune responses. In this regard,a discrepancy in autoimmune
disease severity was observed between vitamin D3-deﬁcient and
VDR null mice although both yield rickets. Vitamin D3-deﬁcient
mice with a functional VDR develop autoimmunity more rapidly
compared to VDR null mice or WT mice [13,14], with a more
aggressive and accelerated type of disease [11,12]. In addition,
1a,25(OH)2D3 treatment has been shown to prevent autoimmuni-
ty [19]. In contrast, acute experimental inﬂammatory bowelPlease cite this article in press as: A.-S. Vanherwegen, et al., The phenotyp
affected by the absence of VDR or its ability to bind 1a,25-dihydroxyvitam
j.jsbmb.2015.08.010disease was worse when either VDR or its ligand were absent [20].
Such disparity between absence of either ligand or receptor are
also described for other members of the nuclear receptor family
[21]. As vitamin D3-deﬁcient mice present more severe symptoms
of autoimmunity, immune cells presenting an unliganded VDR
could promote deregulated immune responses leading to an
imbalance in the immune environment in these mice. In this
regard, myeloid or conventional DCs, as central players in the
initiation and regulation of immune responses, were evaluated
after differentiation of bone marrow precursors derived from WT,e and function of murine bone marrow-derived dendritic cells is not
in D3, J. Steroid Biochem. Mol. Biol. (2015), http://dx.doi.org/10.1016/
6 A.-S. Vanherwegen et al. / Journal of Steroid Biochemistry & Molecular Biology xxx (2015) xxx–xxx
G Model
SBMB 4473 No. of Pages 7VDR null and VDR DAF-2 mice, for their immunogenic phenotype
and T cell stimulatory capacity in vitro. To our surprise, both
immature and mature BMDCs generated from the VDR DAF-2 mice
did not express higher levels of the antigen-presenting molecule
MHC-II nor the co-stimulatory molecules CD40, CD80 and CD86.
Similarly, VDR null-derived DCs either left unstimulated or
stimulated with LPS and IFN-g did not present increased
expression levels of MHC-II and CD86, as compared to WT DCs.
Additionally, the gene expression levels and protein production of
pro-inﬂammatory cytokines and chemokines were mostly not
altered in stimulated DCs with an unliganded or functionally
absent VDR, as compared to WT DCs. Finally, the observed absence
of a more immunogenic DC phenotype was conﬁrmed, as VDR
DAF-2 DCs did not show an elevated T cell stimulatory capacity, as
compared to WT-derived DCs, when cultured in vitro with
CD4+CD25 T cells. A weakness of the current study is the strong
maturation stimulus, which might overrule subtle differences of
genetic modiﬁcations that might be visible at an immature stage.
However, ﬂow cytometric analysis of unstimulated DCs did either
not show differences between the three mouse strains. Therefore,
it is very unlikely that the T cell stimulatory capacity of these
immature DCs will be affected.
Ablation of the VDR in mice or loss-of-function mutation of the
VDR in humans also results in total body alopecia and the
formation of dermal cysts, while this hair and skin phenotype has
not been observed in mice or humans with a vitamin D3 deﬁciency
[15]. Extensive research has revealed that in the hair follicles, the
VDR is associated with the co-repressor Hairless. This interaction
between VDR and repressor is independent of its ligand 1a,25
(OH)2D3 nor of the AF-2 region of the receptor [22]. Therefore,
mutations in the AF-2 domain do not affect the hair cycle, while the
expression of other genes is hampered, resulting in rickets [23].
However, as vitamin D3 deﬁciency rather than absence of the VDR
and possible associated repressors, is able to induce more severe
autoimmune disease phenotypes, it is unlikely that the molecular
pathways behind these immune observations will be the same. The
association of a repressor, or alternatively co-activators in case of
negative VDREs, is in this case strictly dependent on the absence of
1a,25(OH)2D3 as vitamin D3 supplementation can prevent
autoimmunity. The exact molecular mechanisms by which an
unliganded VDR acts in autoimmunity still remain to be elucidated.
As stated above, the VDR belongs to a family of nuclear
receptors that are able to bind genomic targets even in absence of
ligand. Recently, 2340 genomic VDR binding sites were detected by
chromatin immunoprecipitation (ChIP) analysis in THP-1 human
monocyte leukemia cells, of which 520 sites (20%) were unique to
the unstimulated condition [24]. This indicates that the VDR is able
to closely interact with other transcription factors in the
transcriptional control of key cytokines in BMDCs. For example,
in the current study, we observed an up-regulation of il-12p40 and
tnf-a in VDR null DCs, as compared to WT and VDR DAF-2 DCs. The
ligand-VDR complex is known to interfere with the signaling of
transcription factors such as the nuclear factor of activated T cells
(NFAT) and nuclear factor kB (NF-kB) [25,26], via obstruction of its
activation and genomic binding, which results in the 1a,25
(OH)2D3-mediated down-regulation of il-12p40 [27,28]. In addi-
tion, reduced levels of the inhibitor of NF-kB were observed in VDR
null cells [29]. Due to the loss of DNA binding in VDR null DCs, the
VDR will no longer hinder the binding of a more activated NF-kB in
the promoter region of the pro-inﬂammatory cytokines, hereby
increasing its expression upon maturation. This enhanced gene
transcription was however not reﬂected in increased secretion of
IL-12p70 nor of TNF-a protein into the supernatant of the DC
cultures. Often a poor correlation between mRNA and protein
levels is observed due to several regulatory mechanisms in the
transcriptional and translational process. For example, mRNAPlease cite this article in press as: A.-S. Vanherwegen, et al., The phenotyp
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j.jsbmb.2015.08.010levels can be inﬂuenced by post-transcriptional processing or RNA
binding, reducing the amount available for protein translation.
Furthermore, post-translational modiﬁcations regulate protein
stability and the protein turnover rate [30].
Although a previously published study showed increased
expression levels of inﬂammatory markers like MHC-II and
CD86 in BMDCs derived from VDR null diabetes-prone NOD mice
[13], we did not observed these alterations here in BMDCs from the
VDR null model. The VDR molecule is constitutively or after
activation expressed in other immune cells as well [4]. Therefore it
is possible that an unliganded VDR affects another immune cell
type instead of the DC, thereby causing a more severe autoimmune
presentation. Macrophage function has been reported to be
impaired by vitamin D3 deﬁciency, while macrophage chemotaxis,
phagocytosis and respiratory burst capacity were normal in VDR
null mice. Remarkably, changes in T cell behavior are shown in VDR
null mice, while no abnormalities are detected in vitamin D3-
deﬁcient mice [3]. Addressing the implication of an unliganded
VDR in these other immune cells requires further investigations.
The VDR null strain used in this study was generated through a
targeted deletion of the ﬁrst zinc ﬁnger domain in the DBD of the
nuclear receptor [16]. The resulting truncated VDR protein
however is still able to bind 1a,25(OH)2D3 [17]. Locally increased
concentrations of 1a,25(OH)2D3 are therefore able to mediate
rapid, non-genomic effects and should be taken into account.
Especially as the VDR null mouse model has been reported to
present with hypervitaminosis D, due to the absent VDR-mediated
induction and inhibition of vitamin D-metabolizing enzymes
CYP24A1 and CYP27B1, respectively, as part of a negative feedback
loop. However, in order to elicit immunomodulatory effects, 1a,25
(OH)2D3 requires supraphysiological doses [31]. In addition, we did
not observe any differences in DC phenotype or function between
the three studied mouse strains.
In conclusion, we have demonstrated in the current study that
the presence of an unliganded VDR did not affect the phenotype of
myeloid BMDCs, which was represented by an unaltered surface
expression of antigen-presenting and co-stimulatory molecules,
no changes in cytokine production and a similar T cell stimulatory
capacity as compared to WT or VDR null DCs.
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